Janux Therapeutics Inc. – Filings and Transcripts

NASDAQ: JANX
Share price (6/5/26): $13.36
Market cap (6/5/26): $815 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Ownership Filter

Doyle Janeen Noel

Doyle Janeen Noel

Janus Henderson Group plc

State Street Corporation

News Filter

Reports First Quarter 2026 Financial Results and Business Highlights

Change in Directors, Officers or Compensation

Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Announces Collaboration and Exclusive Worldwide License Agreement With Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors

Reports Third Quarter 2025 Financial Results and Business Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness